Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 week ago Contract award

Polska - Produkty farmaceutyczne - ZP/CZD/154/25 DOSTAWA PRODUKTÓW LECZNICZYCH STOSOWANYCH W PROGRAMACH LEKOWYCH - 7 pakietów.

Awarded Poland Warszawski stołeczny Medical equipment & pharmaceuticals

Buyer Instytut "Pomnik-Centrum Zdrowia Dziecka"

€4.6M awarded value · €4,620,514

Key facts

Awarded
Procedure
Open procedure
  1. Awarded
  2. Published
  3. Contract ends, estimated May 2027
View the official notice Watch this tender

This contract runs about 15 months, so it is back on the market around May 2027. Log in

Awarded to

Sanofi Sp. z o.o.; Lek S.A.; Urtica Sp.z o.o.; Roche Polska Sp. z o.o.; AstraZeneca Kft

Awarded value
€4,620,514
Award date
Bids received
8 over 7 lots
Back on the market
May 2027 How we know

When this contract comes back

estimated from the stated duration

This contract runs about 15 months, so it is back on the market around May 2027.

Every contract expiring, on the radar

Description

Przedmiotem zamówienia jest dostawa produktów leczniczych stosowanych w programach lekowych - 7 pakietów na zasadach określonych w projektowanych postanowieniach umowy w ilościach wynikających z bieżących potrzeb i w terminach wynikających z zawartej umowy. Zamawiający dopuszcza składanie ofert częściowych na pakiety, wówczas wykonawca może złożyć ofertę na wybrany pakiet lub wszystkie pakiety wymienione w Załączniku nr 1 do SWZ (OPZ). Przedmiotem zamówienia jest Ravulizumabum, koncentrat do sporządzania roztworu do infuzji, 300 mg/3ml. Produkt leczniczy do zastosowania w programie lekowym B.95 Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest: 1. Agalzydaza beta, proszek do przygotowania koncentratu do sporządzania roztworu do infuzji, w dawce 35 mg, lek do stosowania w programie lekowym B.104 2. Agalzydaza beta, proszek do przygotowania koncentratu do sporządzania roztworu do infuzji, w dawce 5 mg, lek do stosowania w programie lekowym B.104 Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest Alglukozydaza alfa, proszek do przygotowania koncentratu do sporządzania roztworu do infuzji, fiolka 50 mg, lek do stosowania w programie lekowym B.22 Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest Imigluceraza, proszek do przygotowania koncentratu do sporządzania roztworu do infuzji, fiolka 400 j.m., lek do stosowania w programie lekowym B.23 Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest Natalizumabum 300 mg, koncentrat do sporządzania roztworu do infuzji, 1 fiol. 15 ml, lek do stosowania w programie lekowym B.29 Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest: 1. Nivolumabum 10 mg/ml x 1 fiol. 4 ml; koncentrat do sporządzania roztworu do infuzji. 2. Nivolumabum 10 mg/ml x 1 fiol. 10 ml; koncentrat do sporządzania roztworu do infuzji. Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.; Przedmiotem zamówienia jest Risdiplamum, proszek do sporządzania roztworu doustnego 0,75 mg/ml, butelka 60 mg, lek do stosowania w programie lekowym B.102.FM Szczegółowe informacje na temat zakresu zawarte są w formularzu cenowym zał. nr 5 do SWZ.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

What this buyer has paid before

Based on 89 comparable contracts this buyer awarded in this sector over the last 4 years.

This award
€4.6M
Median award
€319,337
Middle half of past awards
€138,987 to €578,114

The award is larger than three in four past awards.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Instytut "Pomnik-Centrum Zdrowia Dziecka"

Poland

notices in the register
342
awards
131
awarded in total
€308.7M

Who wins its contracts

Many suppliers
different companies won its awards
118
of the awards went to the three most frequent winners
5%
of its calls state an estimated value
61%

Based on 122 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.9
of those lots received a single tender
52%
of the awards went to companies based in another country
0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Awards most often to

  1. Transition Technologies Science Sp. z o.o. 2 awards €1.6M
  2. CompuGroup Medical Polska sp. z o.o. 2 awards €1.6M
  3. Barbara Stańczyk Neomed 2 awards €603,664

11 open tenders right now

Market context

open now in Medical equipment & pharmaceuticals
8,192
median open notice
€303,562

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,373
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,462

Based on 22,919 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Award date
    Was: February 10, 2026
    Now: February 10, 2026
    Scope and criteria
    The description was expanded. Re-read it before you bid.
    Award value
    Was: €4,643,699
    Now: €4,620,514

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Open now

Awarded before

Never miss a tender like this

980 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language